Gpr55 deficiency crucially alters cardiomyocyte homeostasis and counteracts angiotensin II induced maladaption in female mice

Br J Pharmacol. 2025 Feb;182(3):670-691. doi: 10.1111/bph.17350. Epub 2024 Oct 20.

Abstract

Background and purpose: Cannabis stimulates several G-protein-coupled-receptors and causes bradycardia and hypotension upon sustained consumption. Moreover, in vitro studies suggest an interference of cannabinoid-signalling with cardiomyocyte contractility and hypertrophy. We aimed at revealing a functional contribution of the cannabinoid-sensitive receptor GPR55 to cardiomyocyte homeostasis and neurohumorally induced hypertrophy in vivo.

Experimental approach: Gpr55-/- and wild-type (WT) mice were characterized after 28-day angiotensin II (AngII; 1·μg·kg-1 min-1) or vehicle infusion. In isolated adult Gpr55-/- and WT cardiomyocytes, mitochondrial function was assessed under naïve conditions, while cytosolic Ca2+ handling was additionally determined following application of the selective GPR55 antagonist CID16020046.

Key results: Gpr55 deficiency did not affect angiotensin II (AngII) mediated hypertrophic growth, yet, especially in females, it alleviated maladaptive pro-hypertrophic and -inflammatory gene expression and improved inotropy and adrenergic responsiveness compared to WT. In-depth analyses implied increased cytosolic Ca2+ concentrations and transient amplitudes, and accelerated sarcomere contraction kinetics in Gpr55-/- myocytes, which could be mimicked by GPR55 blockade with CID16020046 in female WT cells. Moreover, Gpr55 deficiency up-regulated factors involved in glucose and fatty acid transport independent of the AngII challenge, accelerated basal mitochondrial respiration and reduced basal protein kinase (PK) A, G and C activity and phospholemman (PLM) phosphorylation.

Conclusions and implications: Our study suggests GPR55 as crucial regulator of cardiomyocyte hypertrophy and homeostasis presumably by regulating PKC/PKA-PLM and PKG signalling, and identifies the receptor as potential target to counteract maladaptation, adrenergic desensitization and metabolic shifts as unfavourable features of the hypertrophied heart in females.

Keywords: CID16020046; G‐protein coupled receptor GPR55; angiotensin II; cannabinoid receptor; cardiomyocyte homeostasis; hypertrophy.

MeSH terms

  • Angiotensin II*
  • Animals
  • Calcium / metabolism
  • Female
  • Homeostasis* / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout*
  • Myocytes, Cardiac* / drug effects
  • Myocytes, Cardiac* / metabolism
  • Receptors, Cannabinoid* / metabolism
  • Receptors, G-Protein-Coupled / deficiency
  • Receptors, G-Protein-Coupled / genetics
  • Receptors, G-Protein-Coupled / metabolism
  • Resorcinols

Substances

  • Angiotensin II
  • GPR55 protein, mouse
  • Receptors, Cannabinoid
  • Receptors, G-Protein-Coupled
  • 4-(3-3,4-p-menthadien-(1,8)-yl)olivetol
  • Calcium
  • Resorcinols